Thomas Edward Rogers
Monsanto
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Thomas Edward Rogers.
Annual Reports in Medicinal Chemistry | 1996
V. Wayne Engleman; Michael S. Kellogg; Thomas Edward Rogers
Publisher Summary Integrin research is rapidly evolving. Anti-platelet agents are in the clinic and discovery efforts are ranging across a spectrum of opportunities for the treatment of disease, both metabolic and infectious. The complex, dynamically regulated phenotypic expression of plasma membrane linked glycoprotein and carbohydrate molecules and their ability to uniquely recognize soluble and insoluble ligands helps define the biological basis of current concepts of development, life, and death. As understanding of the pivotal role of cell adhesion and communication in normal life processes improves, further discernment of the consequences of atypical adhesion and communication becomes possible. The promise of more lucid molecular pathology is modification of disease states through drug treatment. This chapter discusses the integrin class of cell adhesion molecules. The focus remains toward the pathologies for which disease modifying agents could be developed based on the understanding of the specific molecular interactions. The integrin superfamily is made up of structurally and functionally related glycoproteins distributed over three families— namely, the very late antigens (VLA) family (β1), the Leucam family (β2), and the cytoadhesin family (β3). Integrins are α,β heterodimeric, transmembrane receptor molecules found in combinations on every mammalian cell type except red blood cells. There are 15 α subunits and 8 β subunits that are noncovalently linked and expressed on the surfaces of cells in combination. The integrin name has been derived from their role in “integrating” the extracellular matrix (ECM) with the cytoskeleton.
Tetrahedron | 1991
James P. Coleman; Richard C. Hallcher; D.E. HcMackins; Thomas Edward Rogers; J.H. Wagenknecht
An efficient, practical, electrochemical system was developed for the synthesis of a mixture of 4-acetoxy-5-hexenoic acid and trans-6-acetoxy-4-hexenoic acid via manganese (III)-mediated oxidation of acetic acid-acetic anhydride in the presence of butadiene. Copper (II) co-catalyst enhanced the efficiency of this oxidation and copper (I) was shown to catalyze in situ conversion of the acetoxyhexenoic acids into γ-vinyl-γ- butyrolactone.
Journal of Applied Electrochemistry | 1983
J.H. Wagenknecht; James P. Coleman; Richard C. Hallcher; Dudley E. McMackins; Thomas Edward Rogers; W. G. Wagner
The electrochemical oxidation of manganous ion to manganic ion in acetic acid may be efficiently carried out in a parallel plate undivided cell. Reduction of manganic ion to manganous ion at the cathode is a relatively inefficient reaction, allowing the formation of solutions of manganic ion as high as 0.05 mol dm−3, at greater than 80% current efficiency. The effects of the major variables have been evaluated.
Archive | 1989
Thomas Edward Rogers; Steven Haynes Gray; Balekudru Devadas; Steven P. Adams
Journal of Organic Chemistry | 1993
Joseph G. Rico; Richard John Lindmark; Thomas Edward Rogers; Philippe R. Bovy
Archive | 1990
Thomas Edward Rogers; Balekudru Devadas; Steven Haynes Gray; Steven P. Adams
Archive | 1986
Thomas Edward Rogers
Archive | 2001
Ish Kurmar Khanna; Michael Clare; Alan F. Gasiecki; Thomas Edward Rogers; Barbara B. Chen; Mark A. Russell; Hwang-Fun Lu
Archive | 1990
Thomas Edward Rogers; Lowell R. Smith
Archive | 1983
Thomas Edward Rogers; Robert E. Jansson; Manuel M. Baizer